By October, the company should have the Back trial recruiting and running, and the GvHD adult trial up and running.
Assuming the other 4 applications all result in more trials required, and pediatric GVHD' s is rejected, which is the worst possible outcome in my opinion, mid 2025 we should have an idea if the trials are not able to make the end points or not.
By October, the company should have the Back trial recruiting...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.78 |
Change
0.255(16.7%) |
Mkt cap ! $2.032B | |||
| Open | High | Low | Value | Volume |
| $1.74 | $1.83 | $1.71 | $27.76M | 15.59M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 30000 | $1.78 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.79 | 48074 | 4 |
View Market Depth
| Last trade - 16.10pm 14/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |